THE EFFECT OF CO2 THERAPY AND ITS COMBINATIONS ON INFLAMMATORY ACTIVITY AND IMMUNE STATUS: AN EXPERIMENTAL STUDY
DOI:
https://doi.org/10.15674/0030-59872025130-36Keywords:
Carboxytherapy carbon dioxide, Carboxytherapy, carbon dioxide, inflammation, neutrophils, lymphocytes, diclofenac, chondroitin sulfate, carrageenan modelAbstract
Osteoarthritis (OA) is a chronic degenerative disease characterized by cartilage destruction, inflammation, and autoimmune processes. The limited effectiveness of current therapies has generated interest in alternative approaches, such as carboxytherapy, which possesses anti-inflammatory and regenerative properties. Objective. To evaluate the effects of carboxytherapy (CO2) in mono- and combination therapy on a carrageenan-induced model of inflammation in rats by assessing leukocyte differential counts and integral indices. Methods. The study was conducted o n 56 white rats divided i nto 7 groups (n = 8): control (intact and carrageenan-induced), mono- and combination therapy with CO2 in conjunction with diclofenac or chondroitin. Changes in the leukocyte differential counts and integral indices (NMR, NLR, LSI, LI, IIR) were evaluated. Results. CO2 monotherapy (Group V) reduced the NMR (Neutrophil-to-Monocyte Ratio) by 25.4 % (15.60 ± 2.95 vs. 20.92 ± 8.89 in Group II, p < 0.001). The Leukocyte Index (LI) increased by 82.2 % (1.471 ± 0.155 vs. 1.791 ± 0.191, p = 0.001). The combination of CO2 with diclofenac (Group VI) reduced NMR by 68.3 % (6.61 ± 2.72, p < 0.001) and increased LI by 103.1 % (3.637 ± 0.770, p < 0.001). CO2 combined with chondroitin (Group VII) reduced the NLR (Neutrophil-to-Lymphocyte Ratio) by 48.6 % (0.290 ± 0.0938, p < 0.001) and increased LI by 121.7 % (3.847 ± 1.421, p < 0.001). In Groups VI and VII, there was a significant decrease in band neutrophils (by 79.2 % and 75.0 %, respectively) and an increase in lymphocytes (by 72.2 % and 70.9 %, p < 0.001). Conclusions. Carboxytherapy modulates the inflammatory response and enhances the immune response. The best results were observed with combined CO2 therapy with diclofenac or chondroitin, confirming their potential in reducing inflammation and stimulating regeneration.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 Viktor Shtroblia

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.
Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.
The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).